The OPEN Foundation has published hundreds of blog posts since its inception in 2007, including interviews with many leading psychedelic experts. On this page, you can access our publications that address various interdisciplinary topics, substances, and therapies.
Even if psychedelics have long been regarded as tools to explore or expand one’s consciousness, they have only been picked up by consciousness researchers rather recently. We asked Enzo Tagliazucchi to give us his perspective on how psychedelics can be used in consciousness research.
Being one of the most powerful psychedelics we know, it is not strange that DMT has become the subject of numerous speculations over the years.
In this short highlight from our previous convention, neuroscientist Robin Carhart-Harris (PhD) compares the idea of ego-dissolution to the “overview” effect experienced by astronauts.
When MAPS founder Rick Doblin was in Amsterdam for our event on MDMA research, he sat down with journalist Thijs Roes for a wide-ranging conversation.
Over the last decade, psychedelics have made a comeback in the world of research and academia. This has caused a wave of new publicity, acceptance, and enthusiasm around psychedelic science.
Until now, MDMA has mostly been studied in the context of treating PTSD and helping with autism. Psychiatrist Ben Sessa is now conducting the world’s
Altered States: Buddhism and Psychedelic Spirituality in America. Douglas Osto. Columbia University Press, 2016. ISBN 978-0231177306 While many psychedelic enthusiasts claim to resonate with Buddhist
Ketamine has been used for over half a century as an anaesthetic, but interest has been steadily growing in its ability to rapidly decrease depressive
The anthropologist as experimental subject. Courtesy of N. Langlitz ‘Neuropsychedelia: The Revival of Hallucinogen Research since the Decade of the Brain’, Nicolas Langlitz’s 2013 book
Subscribe to the OPEN Foundation’s newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.
By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.